DHS Opioid Detection Resilience Act of 2020 2020-02-04 Introduced in Senate DHS Opioid Detection Resilience Act of 2020

This bill establishes new requirements related to the detection of illicit narcotics at ports of entry.

Specifically, U.S. Customs and Border Protection (CBP) must implement a strategy to ensure chemical screening devices are able to identify narcotics at purity levels equal to or less than 10%, or provide an alternate method for identifying narcotics at lower purity levels. The CBP must also test new chemical screening devices at various purity levels before it commits to their acquisition.

Additionally, the Department of Homeland Security must implement a plan for the long-term development of a centralized spectral database for chemical screening devices.

]]> text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.